Development and validation of a risk prediction model for overall survival in patients with nasopharyngeal carcinoma: a prospective cohort study in China

被引:9
作者
Miao, Siwei [1 ]
Lei, Haike [2 ]
Li, Xiaosheng [2 ]
Zhou, Wei [2 ]
Wang, Guixue [3 ]
Sun, Anlong [2 ]
Wang, Ying [2 ]
Wu, Yongzhong [2 ]
机构
[1] Chongqing Med Univ, Sch Publ Hlth, Dept Hlth Stat, Chongqing 400016, Peoples R China
[2] Chongqing Univ, Canc Hosp, Chongqing Canc Multiom Big Data Applicat Engn Res, Chongqing 400030, Peoples R China
[3] Chongqing Univ, Coll Bioengn, MOE Key Lab Biorheol Sci & Technol, State & Local Joint Engn Lab Vasc Implants, Chongqing 400030, Peoples R China
关键词
Nasopharyngeal carcinoma; Nomogram; Overall survival; Prognosis; TO-LYMPHOCYTE RATIO; PROGNOSTIC VALUE; BIOMARKERS;
D O I
10.1186/s12935-022-02776-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Nasopharyngeal carcinoma (NPC) is prevailing in Southern China, characterized by distinct geographical distribution. Aimed to predict the overall survival (OS) of patients with nasopharyngeal carcinoma, this study developed and validated nomograms considering demographic variables, hematological biomarkers, and oncogenic pathogens in China. Methods: The clinicopathological and follow-up data of the nasopharyngeal carcinoma patients obtained from a prospective longitudinal cohort study in the Chongqing University Cancer Hospital between Jan 1, 2017 and Dec 31, 2019 (n = 1635). Cox regression model was used to tested the significance of all available variables as prognostic factors of OS. And independent prognostic factors were identified based on multivariable analysis to model nomogram. Concordance index (C-index), area under the receiver operating characteristic (AUC), calibration curve, and decision curve analysis (DCA) were measured to assess the model performance of nomogram. Results: Data was randomly divided into a training cohort (1227 observers, about 70% of data) and a validation group (408 observers, about 30% of data). At multivariable analysis, the following were independent predictors of OS in NPC patients and entered into the nomogram: age (hazard ratio [HR]: 1.03), stage (stage IV vs. stage I-II, HR: 4.54), radiotherapy (Yes vs. No, HR: 0.43), EBV (>= 1000 vs.< 1000, HR: 1.92), LAR (> 6.15 vs.<= 6.15, HR: 2.05), NLR (> 4.84 vs. <= 4.84 HR: 1.54), and PLR (> 206.33 vs.<= 206.33, HR: 1.79). The C-indexes for training cohort at 1-, 3- and 5-year were 0.73, 0.83, 0.80, respectively, in the validation cohort, the C-indexes were 0.74 (95% CI 0.63-0.86), 0.80 (95% CI 0.73-0.87), and 0.77 (95% CI 0.67-0.86), respectively. The calibration curve demonstrated that favorable agreement between the predictions of the nomograms and the actual observations in the training and validation cohorts. In addition, the decision curve analysis proved that the nomogram model had the highest overall net benefit. Conclusion: A new prognostic model to predict OS of patients with NPC was developed. This can offer clinicians treatment making and patient counseling. Furthermore, the nomogram was deployed into a website server for use.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Validation of a risk prediction model for COVID-19: the PERIL prospective cohort study
    Mohammedain, Shahd A.
    Badran, Saif
    Elzouki, AbdelNaser Y.
    Salim, Halla
    Chalaby, Ayesha
    Siddiqui, Mya
    Hussein, Yehia Y.
    Rahim, Hanan Abdul
    Thalib, Lukman
    Alam, Mohammed Fasihul
    Al-Badriyeh, Daoud
    Al-Maadeed, Sumaya
    Doi, Suhail A. R.
    FUTURE VIROLOGY, 2023, 18 (15) : 991 - 1000
  • [32] Development and validation of a nomogram model for predicting the risk of venous thromboembolism in lymphoma patients undergoing chemotherapy: a prospective cohort study conducted in China
    Liang, Guanzhong
    Li, Xiaosheng
    Xu, Qianjie
    Yang, Zailin
    Li, Jieping
    Yang, Tao
    Wang, Guixue
    Lei, Haike
    ANNALS OF MEDICINE, 2023, 55 (02)
  • [33] Development and Validation a Nomogram for Predicting Overall Survival in Patients With Intrahepatic Cholangiocarcinoma
    Yuan, Chen
    Hu, Zhigang
    Wang, Kai
    Zou, Shubing
    FRONTIERS IN SURGERY, 2021, 8
  • [34] Development and validation of a novel nomogram for predicting overall survival patients with neuroblastoma
    Zhao, Jin-du
    Lu, Xian-ying
    Chen, Tian -ping
    Duan, Xian-Lun
    Zuo, Wei
    Sai, Kai
    Zhu, Li -ran
    Gao, Qun
    EJSO, 2024, 50 (06):
  • [35] Development and validation of a machine learning-based model to predict postoperative overall survival in patients with soft tissue sarcoma: a retrospective cohort study
    Liu, Xu
    Yuan, Jin
    Wang, Xinfeng
    Yu, Shengji
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (10): : 4731 - 4746
  • [36] Development and validation of a novel prognostic model for long-term overall survival in liposarcoma patients: a population-based study
    Cao, Shuai
    Li, Jie
    Yang, Kai
    Zhang, Jun
    Xu, Jiawei
    Feng, Chaoshuai
    Li, Haopeng
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (12)
  • [37] Application of artificial intelligence for overall survival risk stratification in oropharyngeal carcinoma: A validation of ProgTOOL
    Alabi, Rasheed Omobolaji
    Sjoblom, Anni
    Carpen, Timo
    Elmusrati, Mohammed
    Leivo, Ilmo
    Almangush, Alhadi
    Makitie, Antti A.
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2023, 175
  • [38] Development and validation of a nomogram for predicting the overall survival of prostate cancer patients: a large population-based cohort study
    Zhou, Zheng
    Pu, Jinxian
    Wei, Xuedong
    Huang, Yuhua
    Lin, Yuxin
    Wang, Liangliang
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2022, : 1325 - 1335
  • [39] Development and external validation of a risk-prediction model to predict 5-year overall survival in advanced larynx cancer
    Petersen, Japke F.
    Stuiver, Martijn M.
    Timmermans, Adriana J.
    Chen, Amy
    Zhang, Hongzhen
    O'Neill, James P.
    Deady, Sandra
    Vander Poorten, Vincent
    Meulemans, Jeroen
    Wennerberg, Johan
    Skroder, Carl
    Day, Andrew T.
    Koch, Wayne
    van den Brekel, Michiel W. M.
    LARYNGOSCOPE, 2018, 128 (05) : 1140 - 1145
  • [40] Predicting the overall survival and progression-free survival of nasopharyngeal carcinoma patients based on hemoglobin, albumin, and globulin ratio and classical clinicopathological parameters
    Chen, Zui
    Ling, Jie
    Zhang, Sujuan
    Feng, Yuhua
    Xie, Yangchun
    Liu, Xianling
    Hou, Tao
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (10): : 2600 - 2615